CJ Corp.

IN VITRO DIAGNOSTICS Mergers & Acquisitions ERBA Diagnostics Mannheim GMBH ERBA Diagnostics Inc. Escalon Medical Corp. Drew Scientific Inc. JAS Diagnostics Inc. ERBA Diagnostics Inc. , which is maj

The two lipid lowerers under scrutiny at the FDA this week each use a novel strategy to reduce cholesterol levels, but what other approaches for hypercholesterolemia/dyslipidemia are in the pipeline?

IN VITRO DIAGNOSTICS Mergers & Acquisitions Agilent Technologies Inc. Dako AS Expanding its presence in the diagnostics market, life sciences company Agilent Technologies Inc. will pay $2.2bn in c

Financings In the third quarter of 2011, biopharma start-ups raised $299 million – $48 million more than last quarter, with more than half of the funding going to Series A rounds. ( See Exhibit 1. )Me